Related references
Note: Only part of the references are listed.Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
Charlotte Teunissen et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
The CD14brightCD16+monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population
Manuela Rossol et al.
ARTHRITIS AND RHEUMATISM (2012)
High YKL-40 levels predict mortality in patients with type 2 diabetes
Frederik Persson et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
E. Canto et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients
Hyun Young Park et al.
PLOS ONE (2012)
Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage
Jean-Pierre Louboutin et al.
FASEB JOURNAL (2011)
Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer's disease
Jihye Choi et al.
JOURNAL OF NEUROLOGY (2011)
Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis
Jorge Correale et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
Fabio M. Iwamoto et al.
NEURO-ONCOLOGY (2011)
Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
Richard J. Perrin et al.
PLOS ONE (2011)
Increased YKL-40 expression in patients with carotid atherosclerosis
Annika E. Michelsen et al.
ATHEROSCLEROSIS (2010)
YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Rebecca Craig-Schapiro et al.
BIOLOGICAL PSYCHIATRY (2010)
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
Manuel Comabella et al.
BRAIN (2010)
Elevated Pretreatment Serum Concentration of YKL-40-An Independent Prognostic Biomarker for Poor Survival in Patients With Metastatic Nonsmall Cell Lung Cancer
Ina Thoem et al.
CANCER (2010)
The Chitinase-like Protein YKL-40 Is Secreted by Airway Epithelial Cells at Base Line and in Response to Compressive Mechanical Stress
Jin-Ah Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
YKL-40 Protein Levels and Clinical Outcome of Human Endometrial Cancer
C. Peng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2010)
In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
Dafna Bonneh-Barkay et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Overexpression of YKL-40 is an independent prognostic marker in gastric cancer
Jiong Bi et al.
HUMAN PATHOLOGY (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
YKL-40 is Elevated in Morbidly Obese Patients and Declines After Weight Loss
Moritz Hempen et al.
OBESITY SURGERY (2009)
YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor
Dafna Bonneh-Barkay et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis
L. K. Fisniku et al.
BRAIN (2008)
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
M. Tintore et al.
NEUROLOGY (2008)
A chitinase-like protein in the lung and circulation of patients with severe asthma
Geoffrey L. Chupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The phylogenetically conserved molluscan chitinase-like protein 1 (Cg-Clp1), homologue of human HC-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes
Fabien Badariotti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Baseline MRI predicts future attacks and disability in clinically isolated syndromes
M. Tintore et al.
NEUROLOGY (2006)
The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation
Heather F. Bigg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma
K Brasso et al.
PROSTATE (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases
J Brettschneider et al.
JOURNAL OF NEUROLOGY (2005)
Increased serum YKL-40 in patients with pulmonary sarcoidosis - a potential marker of disease activity?
JS Johansen et al.
RESPIRATORY MEDICINE (2005)
Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response
C Sunderkötter et al.
JOURNAL OF IMMUNOLOGY (2004)
Early detection and prognosis of ovarian cancer using serum YKL-40
J Dupont et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Blood monocytes consist of two principal subsets with distinct migratory properties
F Geissmann et al.
IMMUNITY (2003)
Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease
I Vind et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activity
R Peltomaa et al.
RHEUMATOLOGY INTERNATIONAL (2001)
Identification of a novel acidic mammalian chitinase distinct from chitotriosidase
RG Boot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions
K Vos et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Serum YKL-40 is increased in patients with hepatic fibrosis
JS Johansen et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
